What does microarray-based gene expression profiling tell us in terms of diagnosing and treating breast cancer? How is this technology changing our perceptions of breast cancer? Dr. Lajos Pusztai, associate professor of medicine at the University of Texas M.D. Anderson Cancer Center, discusses some clinical applications of a multigene assay. Dr. Lee Freedman hosts.
Exploring the Molecular Origins of Breast Cancer
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What does microarray-based gene expression profiling tell us in terms of diagnosing and treating breast cancer? How is this technology changing our perceptions of breast cancer? Dr. Lajos Pusztai, associate professor of medicine at the University of Texas M.D. Anderson Cancer Center, discusses some clinical applications of a multigene assay. Dr. Lee Freedman hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Love Story: Lipid Education for Women’s Heart Health
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Navigating Myasthenia Gravis in Adolescents and Young Adults
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?